CAPPELLACCI, Loredana
 Distribuzione geografica
Continente #
NA - Nord America 17.723
EU - Europa 9.413
AS - Asia 6.636
SA - Sud America 929
AF - Africa 170
Continente sconosciuto - Info sul continente non disponibili 53
OC - Oceania 24
AN - Antartide 1
Totale 34.949
Nazione #
US - Stati Uniti d'America 17.090
CN - Cina 3.014
RU - Federazione Russa 2.230
IT - Italia 2.023
SG - Singapore 1.747
PL - Polonia 1.316
DE - Germania 943
BR - Brasile 784
UA - Ucraina 605
HK - Hong Kong 593
CA - Canada 554
SE - Svezia 549
GB - Regno Unito 507
FR - Francia 448
FI - Finlandia 317
TR - Turchia 257
KR - Corea 252
VN - Vietnam 207
IN - India 156
IE - Irlanda 146
JP - Giappone 72
CZ - Repubblica Ceca 68
IR - Iran 56
MX - Messico 56
ZA - Sudafrica 54
EU - Europa 52
BE - Belgio 41
ES - Italia 40
NL - Olanda 40
AR - Argentina 39
ID - Indonesia 38
BD - Bangladesh 37
IQ - Iraq 33
NG - Nigeria 32
EC - Ecuador 28
PK - Pakistan 27
CO - Colombia 25
AT - Austria 24
VE - Venezuela 18
MA - Marocco 17
CL - Cile 16
PH - Filippine 16
RO - Romania 16
RS - Serbia 16
AU - Australia 15
AE - Emirati Arabi Uniti 14
GR - Grecia 14
CI - Costa d'Avorio 12
CM - Camerun 12
MY - Malesia 12
TW - Taiwan 12
IL - Israele 11
SA - Arabia Saudita 10
TH - Thailandia 10
AL - Albania 9
DZ - Algeria 9
JO - Giordania 9
KE - Kenya 9
CH - Svizzera 8
EG - Egitto 8
LT - Lituania 8
PT - Portogallo 8
UZ - Uzbekistan 7
DK - Danimarca 6
NZ - Nuova Zelanda 6
PE - Perù 6
AZ - Azerbaigian 5
BO - Bolivia 5
DO - Repubblica Dominicana 5
EE - Estonia 5
KG - Kirghizistan 5
TN - Tunisia 5
UY - Uruguay 5
HU - Ungheria 4
KH - Cambogia 4
KZ - Kazakistan 4
LB - Libano 4
MW - Malawi 4
NP - Nepal 4
TT - Trinidad e Tobago 4
YE - Yemen 4
BA - Bosnia-Erzegovina 3
BG - Bulgaria 3
CR - Costa Rica 3
LV - Lettonia 3
SK - Slovacchia (Repubblica Slovacca) 3
AM - Armenia 2
ET - Etiopia 2
GE - Georgia 2
GU - Guam 2
HN - Honduras 2
JM - Giamaica 2
LU - Lussemburgo 2
MD - Moldavia 2
OM - Oman 2
PA - Panama 2
SI - Slovenia 2
AF - Afghanistan, Repubblica islamica di 1
AQ - Antartide 1
BF - Burkina Faso 1
Totale 34.921
Città #
Fairfield 1.547
Jacksonville 1.505
Woodbridge 1.384
Ashburn 1.355
Houston 966
Warsaw 941
Chandler 937
Ann Arbor 763
Wilmington 700
Singapore 699
Dallas 687
Seattle 674
Boardman 621
Hong Kong 573
Camerino 533
Cambridge 482
Beijing 472
Nanjing 470
Toronto 387
Kraków 361
Los Angeles 274
The Dalles 267
San Mateo 251
New York 237
Seoul 223
Tongling 218
Lawrence 204
Princeton 204
Istanbul 199
Columbus 190
Düsseldorf 179
Dearborn 177
Nanchang 171
Ogden 160
Helsinki 143
Dublin 139
Moscow 115
Buffalo 112
Lachine 112
Shanghai 110
London 107
Chicago 106
Milan 101
Tianjin 90
Shenyang 89
Guangzhou 83
Hebei 81
Kunming 81
São Paulo 80
Centro 77
Jiaxing 70
Ho Chi Minh City 66
San Diego 66
Ancona 63
Jinan 59
Tokyo 56
Falls Church 55
Washington 54
Bremen 52
Hangzhou 51
Leawood 48
Stockholm 48
Changsha 46
Redwood City 44
Rome 43
Venezia 43
Brno 42
Dong Ket 42
Brooklyn 41
Munich 40
Brussels 39
Council Bluffs 39
Santa Clara 39
Denver 37
Zhengzhou 37
Johannesburg 36
Wuhan 36
Hanoi 34
Hefei 34
Macerata 34
Frankfurt am Main 32
Philadelphia 32
Phoenix 30
Chennai 29
Redondo Beach 29
Verona 27
Auburn Hills 26
Rio de Janeiro 26
Atlanta 25
Acquaviva 24
Ankara 24
Montreal 24
Mumbai 24
Nuremberg 24
Ardabil 23
Macapá 23
Mexico City 23
San Francisco 23
Perugia 22
Iesi 21
Totale 22.542
Nome #
Trypanosoma brucei inhibition by essential oils from medicinal and aromatic plants traditionally used in Cameroon (Azadirachta indica, Aframomum melegueta, Aframomum daniellii, Clausena anisata, Dichrostachys cinerea and Echinops giganteus) 434
Diverse biological effects of the ajwain oil from Iranian Trachyspermum ammi 421
CHEMICAL COMPOSITION, ANTIMICROBIAL AND ANTIPROLIFERATIVE ACTIVITIES OF THE ESSENTIAL OIL FROM CAMEROONIAN ERIGERON FLORIBUNDUS 383
Biological activities of the essential oil from Erigeron floribundus 376
Mexican sunflower (Tithonia diversifolia, Asteraceae) volatile oil as a selective inhibitor of Staphylococcus aureus nicotinate mononucleotide adenylyltransferase (NadD) 338
An overlooked horticultural crop, Smyrnium olusatrum, as a potential source of compounds effective against African trypanosomiasis 308
CHEMICAL COMPOSITION OF TEN ESSENTIAL OILS FROM CALOPHYLLUM INOPHYLLUM LINN AND THEIR TOXICITY AGAINST ARTEMIA SALINA 297
The crop-residue of fiber hemp cv Futura 75: from a waste product to a source of botanical insecticides 291
Exploring the Role of N6‐Substituents in Potent Dual Acting 5'‐C‐Ethyltetrazolyladenosine Derivatives: Synthesis, Binding, Functional Assays, and Antinociceptive Effects in Mice 283
Essential oil and furanosesquiterpenes from myrrh oleo-gum resin: a breakthrough in mosquito vector management 282
Mosquito control with green nanopesticides: towards the One Health approach? A review of non-target effects 268
SINTESI E VALUTAZIONE BIOLOGICA DI INIBITORI DI ENZIMI CHIAVE NEL METABOLISMO DI BIOFILM BATTERICI 267
4-acyl-5-pyrazolone-based hydrazones as novel anti-Trypanosoma brucei agents: structural design, synthesis and biological evaluation 261
The essential oil from industrial hemp (Cannabis sativa L.) by-products as an effective tool for insect pest management in organic crops 253
Antitrypanosomal activity of Tithonia Diversifolia 251
Identification of Onosma visianii Roots Extract and Purified Shikonin Derivatives as Potential Acaricidal Agents against Tetranychus urticae 247
8-Aza analogues of deaza purine nucleosides. Synthesis and biological evaluation of 8-aza-1-deazaadenosine and 2'-deoxy-8-aza-1-deazaadenosine 246
Isofuranodiene and germacrone from Smyrnium olusatrum essential oil as acaricides and oviposition inhibitors against Tetranychus urticae: impact of chemical stabilization of isofuranodiene by interaction with silver triflate 239
Oviposition inhibitory activity of the Mexican sunflower Tithonia diversifolia (Asteraceae) polar extracts against the two-spotted spider mite Tetranychus urticae (Tetranychidae) 233
2'-C-Methyl analogues of selective adenosine receptor agonists: synthesis and binding studies. 232
Synergized mixtures of Apiaceae essential oils and related plant-borne compounds: larvicidal effectiveness on the filariasis vector Culex quinquefasciatus Say 232
Development of C-Methyl Branched Purine Ribonucleoside Analogs: Chemistry, Biological Activity and Therapeutic Potential 229
8-Azaxanthine derivatives as antagonists of adenosine receptors. 223
Synthesis, conformational analysis, and biological activity of new analogues of thiazole-4-carboxamide adenine dinucleotide (TAD) as IMP dehydrogenase inhibitors 221
Multitarget 1,4-Dioxane Compounds Combining Favorable D2-like and 5-HT1A Receptor Interactions with Potential for the Treatment of Parkinson's Disease or Schizophrenia 219
Targeting Nucleotide Dimers Containing Antiviral Nucleosides 217
8-Aza-1-deaza purine nucleosides as antiviral agents. 215
Structure-Based Design, Synthesis and in vivo Antinociceptive Effects of Selective A1 Adenosine Receptor Agonists 215
Synthesis and antiviral activity of 8-aza analogs of chiral [2-(Phosphono-methoxy)propyl]guanines. 213
2’-C-Methyl derivatives of tecadenoson and 2-chloro-tecadenoson with increased selectivity for human A1 adenosine receptor 212
ATP-mimetics derived from 2 '(3 ')-C-methyladenosine as human P2Y2 agonists 211
A new facile synthesis and antiviral activity of oxazofurin 210
4’-TETRAZOLYL-ALKYL-N6-SUBSTITUTED ADENOSINE DERIVATIVES AS HIGHLY POTENT DUAL ACTING A1 ADENOSINE RECEPTOR AGONISTS AND A3 ADENOSINE RECEPTOR ANTAGONISTS 209
“Third Joint Italian-German Purine Club Meeting - Purinergic Receptors: New Frontiers for Novel Therapies” 205
Exploring the Molecular Mechanisms Underlying the in vitro Anticancer Effects of Multitarget-Directed Hydrazone Ruthenium(II)-Arene Complexes 203
Novel Inhibitors of Inosine Monophosphate Dehydrogenase in Patent Literature of the Last Decade 202
5’-deoxy-5’-N-pyrazolyl-N6-substituded adenosine derivates as A1 adenosine receptor agonists: synthesis and antinociception in mice 202
5’-Carbamoyl Derivatives of 2'-C-Methyl-purine Nucleosides as Selective A1 Adenosine Receptor Agonists: Affinity, Efficacy and Selectivity for A1 Receptor from Different Species. 200
Synthesis and biological activity of novel N6-substituted and 2,N6-disubstituted adenine ribo- and 3'-C-methyl-ribonucleosides as antitumor agents 200
New Half-Sandwich Ruthenium(II) Complexes bearing Hydrazone Ligands: Organometallic Chemistry and Bioactivity 199
Synthesis and Biological Evaluation of NAD Analogs as Human Pyridine Nucleotide Adenylyltransferase Inhibitors 198
Acyclic nucleotides related to clitocine: synthesis and anti-HIV activity 198
5'-CHLORO-5'-DEOXY-N6-(±)-endo-NORBORNYLADENOSINE, A POTENT AND HIGHLY SELECTIVE HUMAN A1 ADENOSINE RECEPTOR AGONIST, PREVENTS HYPERALGESIA/ALLODYNIA AND EARLY OVER-EXPRESSION OF PRO-APOPTOTIC AND PRO-INFLAMMATORY GENES IN A MICE MODEL OF NEUROPATHIC PAIN 197
Rationale for developing novel mosquito larvicides based on isofuranodiene microemulsions 197
Efficacy of Origanum syriacum Essential Oil against the Mosquito Vector Culex quinquefasciatus and the Gastrointestinal Parasite Anisakis simplex, with Insights on Acetylcholinesterase Inhibition 197
Inhibition of HIV-1 replication in macrophages by a heterodinucleotide of lamivudine and tenofovir 196
BIOASSAY-GUIDED FRACTIONATION OF TITHONIA DIVERSIFOLIA SECONDARY METABOLITES AGAINST TRYPANOSOMA BRUCEI 194
From the covalent linkage of drugs to novel inhibitors of ribonucleotide reductase: synthesis and biological evaluation of valproic esters of 3'-C-methyladenosine 192
Insights into the GTP‐dependent allosteric control of c‐di‐GMP hydrolysis from the crystal structure of PA0575 protein from Pseudomonas aeruginosa 190
SYNTHESIS AND PHARMACOLOGICAL CHARACTERIZATION OF RIBOSE-MODIFIED ADENOSINE DERIVATIVES AS P1 RECEPTOR LIGANDS 189
Purine and pyrimidine nucleoside analogs of 3'-C-methyladenosine as antitumor agents 189
A new acyclic heterodinucleotide active against Human Immunodeficiency Virus and Herpes Simplex Virus 188
5′-C-Ethyl-tetrazolyl-N6-Substituted Adenosine and 2-Chloro-adenosine Derivatives as Highly Potent Dual Acting A1 Adenosine Receptor Agonists and A3 Adenosine Receptor Antagonists 188
Identification of highly effective antitrypanosomal compounds in essential oils from the Apiaceae family 188
ADP- and ATP-mimetics derived from 2'(3')-C-methyladenosine as human P2Y1 and P2Y2 receptor ligands 187
8-Aza derivatives of 3-deazapurine nucleosides. Synthesis and in vitro evaluation of antiviral and antitumor activity 186
A new tiazofurin pronucleotide: synthesis and biological evaluation of CycloSaligenyl-tiazofurin monophosphate 185
Stereoselective synthesis of nicotinamide β-riboside and nucleoside analogs 185
Acute and sub-lethal toxicity of eight essential oils of commercial interest against the filariasis mosquito Culex quinquefasciatus and the housefly Musca domestica 184
null 182
N6/5’-DISUBSTITUTED ADENOSINE AND 2-CHLORO-ADENOSINE DERIVATIVES AS POTENT AND SELECTIVE A1 ADENOSINE RECEPTOR AGONISTS: SYNTHESIS, BINDING ASSAYS AND ANTINOCICEPTIVE ACTIVITY IN MICE 182
Inhibition of HIV-1 replication in macrophages by red blood cell-mediated delivery of a heterodinucleotide of lamivudine and tenofovir 182
Exploring the Insecticidal Potential of Boldo (Peumus boldus) Essential Oil: Toxicity to Pests and Vectors and Non-target Impact on the Microcrustacean Daphnia magna 182
Synthesis and antitumor activity of a heterodinucleotide of BVDU and Gemcitabine 181
Preparation of purine and 8-azapurine derivatives for treatment of acquired immune deficiency syndrome. 181
Novel dual acting 5’-C-ethyl-tetrazolyl-N6-substituted adenosine derivatives: synthesis and biological evaluation 181
Pharmacokinetic and antiretroviral activity in mice of oral [P1,P2-bis[2-(adenin-9-yl)ethoxymethyl]phosphonate], a prodrug of 9-(2-phosphonylmethoxyethyl)adenine 181
The A1 Adenosine Receptor as a New Player in Microglia Physiology 179
Synthesis, Biological Evaluation and Molecular Modeling of Ribose-modified Adenosine Analogues as Adenosine Receptor Agonists 179
Isosteric Analogues of Nicotinamide Adenine Dinucleotide Derived from Furanfurin, Thiophenfurin, and Selenophenfurin as Mammalian Inosine Monophosphate dehydrogenase (Type I and II) Inhibitors 179
Dinucleoside polyphosphate NAD analogs as potential NMN adenylyltransferase inhibitors. Synthesis and biological evaluation 178
Synthesis and evaluation of anti-HIV-1 and antitumor activity of 2',3'-didehydro-2',3'-dideoxy-3-deazaadenosine, 2',3'-dideoxy-3-deazaadenosine and some 2',3'-dideoxy-3-deazaadenosine 5'-dialkyl phosphates 177
Synthesis and antiviral evaluation of 1-deaza-8-aza- and 3-deaza-8-aza-purine nucleosides 177
Potent and selective inhibitors of human immunodeficiency virus protease structurally related to L-694,746. 177
Identification of Tagitinin C from Tithonia diversifolia as antitrypanosomal compound using bioactivity-guided fractionation 177
The synergistic apoptotic effects of thiophenfurin, an inosine monophosphate dehydrogenase inhibitor, in combination with retinoids in HL60 cells 176
Synthesis of Triazole-Linked Analogues of c‐di-GMP and Their Interactions with Diguanylate Cyclase 176
8-Aza-analogues of PMEA and PMEG: synthesis and in vitro anti-HIV activity. 175
Synthesis and IMP dehydrogenase (type I and type II) inhibitory activity of isosteric NAD analogs derived from thiophenfurin and furanfurin 175
Synthesis, antitumor activity and crystallographic studies of analogues of tiazofurin 174
NMN/NaMN adenylyltransferase (NMNAT) and NAD kinase (NADK) inhibitors: chemistry and potential therapeutic applications 174
Ligand Design for N,O- or N,N‐Pyrazolone-Based Hydrazones Ruthenium(II)-Arene Complexes and Investigation of Their Anticancer Activity 174
Synthesis and Biological Evaluations of Novel Arene Ru(II) Complexes of 4-acyl-5-pyrazolone-based Hydrazone Ligands 173
Carlina oxide from Carlina acaulis root essential oil acts as a potent mosquito larvicide 173
2'-C-Methyl analogs of selective adenosine receptors agonists: synthesis and binding studies 172
Histone deacetylase inhibition modulates deoxyribonucleotide pools and enhances the antitumor effects of the ribonucleotide reductase inhibitor 3’-C-methyladenosine in leukaemia cells 172
Not just popular spices! Essential oils from Cuminum cyminum and Pimpinella anisum are toxic to insect pests and vectors without affecting non-target invertebrates 172
Synthesis and potency of novel uracil nucleotides and derivatives as P2Y(2) and P2Y(6) receptor agonists 172
5’-CHLORO-5’-DEOXY-N6-SUBSTITUTED ADENOSINE DERIVATIVES: SYNTHESIS, ADENOSINE RECEPTOR AFFINITY AND ANTINOCICEPTIVE ACTIVITY 171
Structure-activity relationships of tiazofurin analogs: synthesis and computational studies of 4'-thio derivatives of thiophenfurin and furanfurin 170
2'-C-Methyl-2-chloro-N6-cyclopentyladenosine, a potent and highly selective A1 adenosine receptor agonist, has antinociceptive activity and modulates RVM on-and-off cell activities 170
Ribose-modified mizoribine analogues: synthesis and biological evaluation 170
Selective inhibition of nicotinamide adenine dinucleotide kinases by dinucleoside disulfide mimics of nicotinamide adenine dinucleotide analogues 170
5'-Chloro-5'-deoxy-N6-(±)-endo-norbornyladenosine, a potent and highly selective human A1 adenosine receptor agonist modulates neuropathic pain in mice. 170
Synthesis, structure, and antiproliferative activity of selenophenfurin, an IMP dehydrogenase inhibitor analogue of selenazofurin. 169
Antitumor effects of novel co-drugs linking histone deacetylase and ribonucleotide reductase inhibitors in hematological tumors 169
Encapsulation of Carlina acaulis essential oil and carlina oxide to develop long‑lasting mosquito larvicides: microemulsions versus nanoemulsions 169
Synthesis and anti-HIV activity of isonucleosides and acyclic nucleotides related to clitocine 169
Synthesis and cytotoxic activity of selenophenfurin, a new inhibitor of IMP dehydrogenase 168
Adenosine receptors as promising targets for the management of ocular diseases 167
Totale 20.940
Categoria #
all - tutte 145.186
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 145.186


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20212.551 0 0 0 0 0 274 506 107 358 157 778 371
2021/20222.295 166 609 62 104 136 116 81 160 192 209 210 250
2022/20232.883 340 60 143 332 320 360 11 203 524 231 269 90
2023/20242.515 296 151 166 81 132 318 130 110 254 133 58 686
2024/20257.310 322 165 661 307 265 360 899 1.791 638 512 369 1.021
2025/20264.858 593 901 892 1.353 976 143 0 0 0 0 0 0
Totale 35.709